EUVIMEDEUVIMED entdecken
Crossref

Scutebarbatine B Exerts Anti‐Breast Cancer Activity by Inducing Cell Cycle Arrest and Apoptosis Through Multiple Pathways

Chong Niu, Ruo-Tong Li, Xiao-Shan Hao, Xiao Qi, Feng-Ze Wang iD, Hong-Rong Fei

Phytotherapy Research · 2025

DOI: 10.1002/ptr.70007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2025. Verfasst von Chong Niu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy (Institute of Pharmaceutical Research), Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong,…. Hauptthemen laut MEDLINE: Apoptosis, Breast Neoplasms, Cell Cycle Checkpoints, Scutellaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Shandong Provincial Natural Science Foundation, China, Shandong ProvincialNatural Science Foundation, China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most commonly occurring cancer among women with high mortality. Identifying effective anticancer compounds to improve the overall survival is imperative. The present study was designed to evaluate the effects and underlying mechanisms of Scutebarbatine B ( SBT ‐B), a diterpenoid alkaloid extracted from Scutellaria barbata D. Don ( S. barbata ), on breast cancer. Cell viability assay, 5‐ethynyl‐2′‐deoxyuridine ( EdU ) assay, immunofluorescence, flow cytometry analysis, TdT ‐mediated dUTP ‐biotin nick end labeling ( TUNEL ) staining, Western blot analysis, 2′,7′‐dichlorodihydrofluorescein diacetate ( DCFH ‐ DA ), and dihydroethidium ( DHE ) staining were performed to elucidate the anticancer mechanisms of SBT ‐B in vitro. Mice xenograft models were used to assess the anticancer properties in vivo. We demonstrated that SBT ‐B suppressed the proliferation of breast cancer cells in a dose‐dependent manner. SBT ‐B treatment induced DNA damage response, G2 /M phase arrest and downregulated the expression of cyclinB1 , cyclinD1 , Cdc2, and p‐Cdc2. SBT ‐B could trigger apoptosis through increasing the cleavage of caspase‐8, caspase‐9 and PARP in breast cancer cells. Additionally, SBT ‐B elevated the generation of intracellular reactive oxygen species ( ROS ). Treatment with a ROS scavenger N‐acetyl cysteine ( NAC ) partially blocked viability reduction and cleavage of caspase‐8 and PARP induced by SBT ‐B. Moreover, SBT ‐B blocked pRB / E2F1 and Akt/ mTOR pathways. Incubation with SBT ‐B increased the expression of IRE1 and phospho‐ JNK . In vivo, SBT ‐B exhibited significant suppression of tumor growth in xenograft models. We demonstrate firstly that SBT ‐B induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells. ROS generation, suppression of oncogenic signaling and activation of IRE1 / JNK pathway play an essential role in the anticancer activity of SBT ‐B. Our study highlights the potential of SBT ‐B as an alternative candidate to treat human breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisBreast NeoplasmsCell Cycle CheckpointsScutellariaDiterpenesAntineoplastic Agents, PhytogenicHumansFemaleAnimalsCell Line, TumorMiceReactive Oxygen SpeciesXenograft Model Antitumor AssaysSignal TransductionCell ProliferationMice, Inbred BALB CDNA DamageMice, NudeCyclin B1Cell SurvivalMCF-7 Cells

Stichwörter der Autor:innen

JNKROSapoptosiscell cycle arrestscutebarbatine B

Substanzen

Reactive Oxygen SpeciesDiterpenesAntineoplastic Agents, PhytogenicCyclin B1

Autor:innen und Institutionen

  • School of Pharmacy (Institute of Pharmaceutical Research), Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.
  • Department of Pathology, Tai' an Central Hospital, Taian, People's Republic of China.
  • School of Life Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, People's Republic of China.

ORCID-Profile: Feng-Ze Wang

Förderung

  • Shandong Provincial Natural Science Foundation, China
  • Shandong ProvincialNatural Science Foundation, China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Niu, C., Li, R. T., Hao, X. S., Qi, X., Wang, F. Z., & Fei, H. R. (2025). Scutebarbatine B Exerts Anti‐Breast Cancer Activity by Inducing Cell Cycle Arrest and Apoptosis Through Multiple Pathways. Phytotherapy Research. https://doi.org/10.1002/ptr.70007

Vancouver

Niu C, Li RT, Hao XS, Qi X, Wang FZ, Fei HR. Scutebarbatine B Exerts Anti‐Breast Cancer Activity by Inducing Cell Cycle Arrest and Apoptosis Through Multiple Pathways. Phytotherapy Research. 2025. doi:10.1002/ptr.70007

BibTeX
@article{Niu2025,
  author = {Niu, Chong and Li, Ruo-Tong and Hao, Xiao-Shan and Qi, Xiao and Wang, Feng-Ze and Fei, Hong-Rong},
  title = {Scutebarbatine B Exerts Anti‐Breast Cancer Activity by Inducing Cell Cycle Arrest and Apoptosis Through Multiple Pathways},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.70007}
}
Kostenlos starten →